Search
Contact
07.11.2023 | KPMG Law Insights, KPMG Law Insights

GWB amendment: These interventions threaten after sector inquiries

On April 5, 2023, the German government passed the 11th amendment to the Act against Restraints of Competition (GWB), the so-called Competition Enforcement Act. The draft law is a turning point in antitrust law: serious antitrust measures can also be taken against law-abiding companies. The planned Section 32 f GWB-E provides for a new intervention instrument which, following a sector inquiry, gives the Federal Cartel Office new and significantly more far-reaching powers to put an end to identified competition problems. As an “ultima ratio,” this should even include an unbundling order, i.e., the breakup of a company.

Up to now, sector inquiries have primarily served the Bundeskartellamt to gain in-depth knowledge of markets and resulted in final reports. It can use these findings in procedures. So far, however, it has only been able to take measures if companies violate specific legal requirements or prohibitions. The sector inquiries into rolled asphalt and cement and ready-mix concrete subsequently led to extensive divestments of joint ventures, which were, however, justified on the grounds of violations of the ban on cartels (Section 1 GWB).

Draft amendment to GWB allows direct intervention following sector investigations for the first time, even against law-abiding companies

Section 32 f GWB-E is now intended to give the Federal Cartel Office the power to intervene and draw direct consequences if a sector inquiry reveals that competition has been disrupted. The paradigm shift is that an intervention under Section 32 f GWB-E is not dependent on proof of concrete violations of antitrust law. This means that action can also be taken against companies that are in themselves law-abiding, insofar as in the view of the Office there is a “significant, persistent or repeated disruption of competition in at least one market or across markets.” For the purpose of concretization, Section 32 f ARC provides for factors listed by way of example, some of which are based on the criteria of Section 18 (1) ARC. 3 GWB, but additionally include in particular market results and practices that are detrimental to competition.

While both German and European antitrust law have hitherto been based on the principle that law-abiding companies do not have to fear sanctions, the draft amendment to the ARC leads to a departure from this proven principle. The German government used Great Britain as a model. The reason given for this is that, unlike the UK Competition and Markets Authority (CMA), German antitrust authorities have so far not been able to intervene effectively in cases where competition is disrupted primarily as a result of market structure.

The GWB amendment provides for these remedies

Remedies typically include primarily behavioral or quasi-structural commitments. These include in particular:

  • granting access to data, interfaces, networks or other facilities,
  • Specifications on business relationships between companies in the markets studied and at different market levels,
  • Commitment to establish transparent, non-discriminatory and open norms and standards by companies,
  • Requirements for certain forms of contracts or contractual arrangements, including contractual arrangements for the disclosure of information,
  • the prohibition of unilateral disclosure of information that favors parallel behavior by companies,
  • the organizational separation of corporate or business units.

However, if such measures are not promising, the Federal Cartel Office can order the unbundling of companies as a last resort. Affected companies can be market-dominant companies or those with overriding cross-market significance for competition (“gatekeepers”). In the event of prior clearance under merger control law, however, there is to be a basic ten-year period of protection of legitimate expectations.

To avert these measures, provision is made for affected companies to reach agreement with the Federal Cartel Office on an undertaking. The commitment to be declared binding by the Federal Cartel Office shall, in return, bind the Federal Cartel Office not to make use of the aforementioned measures.

Increased merger control as a further measure following the sector inquiry

Furthermore, as an additional measure following a sector inquiry, the Federal Cartel Office is to be able to require companies to notify relevant mergers for merger control even if the companies involved have only very low sales. This is intended to prevent corporate concentration. It is true that Section 39 a ARC also allows for an obligation to notify a merger below the notification thresholds of Section 39 ARC under the current legal situation. However, the regulation provided for in Section 32 f GWB-E is tightened. In particular, the sales thresholds will be lowered even further.

Conclusion

If the law is passed in this way, sector inquiries will in future be seen as a sign of potential antitrust intervention measures. Companies affected by sector investigations are therefore strongly advised to seek qualified antitrust advice in a timely manner.

 

Explore #more

22.01.2025 | KPMG Law Insights

The EU packaging regulation sets strict requirements for packaging

The EU has adopted the Packaging Regulation. After the European Parliament adopted the Commission’s draft on April 24, 2024, the EU member states also approved…

09.01.2025 | In the media

KPMG Law strengthens Legal Transformation Managed Services and Legal Corporate Services with two new senior managers

On January 1, KPMG Law strengthened its Transformation Managed Services practice with Jana Sichelschmidt and its Corporate Services practice with Dr. Michaela Lenk. Both are…

06.01.2025 | Deal Notifications

KPMG Law advises on the sale of Käppler & Pausch GmbH

Gabriel Pausch, the co-founder and main shareholder of Käppler & Pausch GmbH, a system supplier for metal assemblies as well as metal and sheet metal…

03.01.2025 | In the media

Interview in Betrieb on the EU money laundering package and its impact

The EU anti-money laundering package harmonizes anti-money laundering and counter-terrorism rules in Europe and introduces new measures such as cash limits of €10,000, identification requirements…

02.01.2025 | In the media

KPMG Law Statement in eMagazin Immobilienanwälte: Creativity meets law in trademark protection

Four Frankfurt, Elbtower, Vonovia: real estate projects and companies are backed by constructs worth millions or even billions. In order to stand out from the…

20.12.2024 | Deal Notifications

KPMG and KPMG Law supported the sale of circular Informationssysteme to the teccle group

Together with the corporate finance/M&A advisors of KPMG AG Wirtschaftsprüfungsgesellschaft (KPMG), KPMG Law Rechtsanwaltsgesellschaft mbH (KPMG Law) advised the shareholders of circular Informationssysteme GmbH (circular)…

19.12.2024 | Press releases

KPMG Law defends Federal Motor Transport Authority against claim for damages in connection with the emissions scandal

The state is not liable to vehicle purchasers for damages. KPMG Law has defended the Federal Motor Transport Authority (KBA) against a civil plaintiff’s state…

18.12.2024 | KPMG Law Insights, KPMG Law Insights

MiCAR – What the new EU regulation means for crypto service providers and issuers

An EU regulation will soon come into force that will regulate crypto assets uniformly throughout Europe. It contains significant new obligations for issuers and crypto…

16.12.2024 | Deal Notifications

KPMG Law advises CERTANIA Holding GmbH on the acquisition of RASG Holdco Ltd.

KPMG Law Rechtsanwaltsgesellschaft mbH (KPMG Law) has provided legal advice to CERTANIA Holding GmbH, a platform of the Munich-based PE firm Greenpeak Partners, on the…

04.12.2024 | Deal Notifications

KPMG Law and KPMG advises Brain Biotech AG on license agreements and monetization of license rights

KPMG Law Rechtsanwaltsgesellschaft mbH and KPMG AG Wirtschaftsprüfungsgesellschaft (KPMG) advised Brain Biotech AG on the monetization of licensing rights with Royalty Pharma and the conclusion…

Contact

Dr. Gerrit Rixen

Partner
Head of Antitrust and Investment Control

Barbarossaplatz 1a
50674 Köln

Tel.: +49 221 2716891052
grixen@kpmg-law.com

© 2024 KPMG Law Rechtsanwaltsgesellschaft mbH, associated with KPMG AG Wirtschaftsprüfungsgesellschaft, a public limited company under German law and a member of the global KPMG organisation of independent member firms affiliated with KPMG International Limited, a Private English Company Limited by Guarantee. All rights reserved. For more details on the structure of KPMG’s global organisation, please visit https://home.kpmg/governance.

 KPMG International does not provide services to clients. No member firm is authorised to bind or contract KPMG International or any other member firm to any third party, just as KPMG International is not authorised to bind or contract any other member firm.

Scroll